slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 40,501-40,530
Pages 2,019
Rows per page 30
Component
40,501-40,530 of 60,557
04
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
05
The slide uses a Gantt-style visualization to show the development status of various drug candidates.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
12
The slide uses a Gantt-style visualization to show the progression of various drug programs (SPY001-SPY230).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
04
The slide uses a contrast-pairs framework to differentiate the company from traditional retail incumbents.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
05
The slide uses a table-like structure to map strategic pillars to operational outcomes.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
53
Standard financial reconciliation table format.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
54
The table shows a consistent growth in ex-TAC gross profit over the 7-year period.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
55
The table provides key financial performance metrics including profitability ratios over a 7-year period.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
56
The table compares standard revenue/gross profit metrics against ex-TAC metrics, showing a consistent improvement in ex-TAC margins over time.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
57
The slide provides a clear breakdown of how 'Adj. Gross Profit Margin' is derived from 'ex-TAC Gross Profit'.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
58
The table shows annual data for 2020-2022 and quarterly data for Q1 2023.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
59
The table provides a bridge between FCF and a custom cash metric by adding back publisher prepayments and interest expenses.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
60
The slide illustrates the impact of upfront cash payments on cash flow versus the smoothed impact on accrual-based gross profit.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
61
Data presented in millions of dollars.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
62
Taboola | Investor Presentation Deck | 64 slidesTaboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Action1 hit
07
The slide compares previous vs updated guidance for FY 2023 and break-even targets.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
11
Includes a footnote explaining the composition of 'Financial income, net'.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
03
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention1 hit
24
Includes GAAP and non-GAAP financial data.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
26
The slide emphasizes the company's improved financial position, specifically the reduction in debt and share buybacks.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
34
Includes definitions for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
36
The table displays projected royalties and milestones for 2023-2026, while the right side details royalty return dates for 2029 and 2031.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
37
The slide uses two distinct colored containers to contrast the two different drug deal structures.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After1 hit
05
The slide uses a waterfall bridge to reconcile equity adjustments between two entities.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
06
The table highlights that these adjustments are CET1 neutral.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
07
The slide provides a breakdown of mark-downs and mark-ups for various asset classes, including loans, real estate, and software, following IFRS 3 acquisition rules.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
08
The table breaks down impacts on Assets, Liabilities, Equity, and CET1 capital.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
10
This is a financial disclosure table detailing the accounting adjustments made during the Credit Suisse acquisition.UBS | Mergers and Acquisitions Presentation Deck | 11 slides · UBS
Regulatory filing Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
10
Includes a non-GAAP disclaimer footnote.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Financials1 hit
19
The table includes footnotes (1-8) for specific line items.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit